Renogram and deconvolution parameters in diagnosis of renal artery stenosis: Variants of background subtraction and analysis techniques

NuklearMedizin

Volumn 46, Issue 6, 2007, Pages 281-290

  Kempi, V ^a,b  

^a Departement of Clinical Physiology   (Sweden)

^b NONE   (Sweden)

Author keywords

Background subtraction; Captopril renography; Correction for loss of parenchyma; Kidney size; Parenchymal insufficiency; Renal artery stenosis

Indexed keywords

CAPTOPRIL; PENTETATE TECHNETIUM TC 99M; TECHNESCAN DTPA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HYPERTENSION; KIDNEY ANGIOGRAPHY; KIDNEY ARTERY STENOSIS; KIDNEY PARENCHYMA; KIDNEY SIZE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; RENOGRAPHY; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; KIDNEY; MIDDLE AGED; RADIOISOTOPE RENOGRAPHY; RENAL ARTERY OBSTRUCTION; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 37349087433     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.3413/nukmed-0071     Document Type: Article

References (31)

1. Adriaensen ME, Kock MC, Stijnen T et al. Peripheral arterial disease: Therapeutic confidence of CT versus digital subtraction angiography and effects on Additional Imaging Recommendations. Radiology 2004; 233: 385-391.
2. Blaufox DM. Should the role of captopril renography extend to the evaluation of chronic renal disease? J Nucl Med 1994; 35: 254-256.
3. Blaufox DM, Fine EJ, Heller S et al. Prospective study of simultaneous orthoiodohippurate and diethylenetriaminepentaacetic acid captopril renography. The Einstein/Cornell Collaborative Hypertension Group. J Nucl Med 1998; 39: 522-528.
4. 99mTc DTPA gamma-camera renography data. In: Radionuclides in nephrology. Joekes AM, Constable AR, Brown NJG, Tauxe WN (eds). London: Academic Press 1982; 113-118.
5. 131I Renocystogram. JAMA 1963; 185: 925-932.
6. Fine EJ. Interventions in renal scintirenography. Semin Nucl Med 1999; 29: 128-145.
7. Fine EJ, Sarkar S. Differential diagnosis and management of renovascular hypertension through nuclear medicine techniques. Semin Nucl Med 1989; 19: 101-115.
8. Fommei E, Ghione S, Hilson AJW et al. Captopril radionuclide test in renovascular hypertension: a European multicentre study. Eur J Nucl Med 1993; 20: 617-623.
9. Goris ML, Daspit SG, McLaughlin P et al. Interpolative background subtraction. J Nucl Med 1976; 17: 744-747.
10. nd ed. New York: John Wiley 2000.
11. Kempi V. A FORTRAN program for deconvolution analysis using the matrix algorithm method with special reference to renography. Comput Methods Progr Biomed 1987; 24: 107-116.
12. 131I-hippuran. Nuklearmedizin 1988; 27: 188-194.
13. Kempi V, Sutton DG. Estimating the diagnostic yield resulting from renography and deconvolution parameters: A logistic regression analysis. J Nucl Med 1995; 36: 147-152.
14. Makoba GI, Nimmon CC, Kouykin V et al. Comparison of corticopelvis transfer index with renal transit times. Nucl Med Commun 1996; 17: 212-215.
15. 99mTc-DTPA renography using multiple background regions: a comparison of methods. Nucl Med Commun 1994; 15: 636-642.
16. 99mTc-DTPA renography: comparison of various regions of interest. Clin Phys 1992; 12: 453-461.
17. Nimmo MJ, Merrick MV, Allan PL. Measurement of relative function, a comparison of methods and assessment of reproducibility. Br J Radiol 1987; 60: 861-864.
18. Prigent A. The diagnosis of renovascular hypertension: the role of captopril renal scintigraphy and related issues. Eur J Nucl Med 1993; 20: 625-644.
19. Prigent A, Cosgriff P, Gates GF et al. Consensus report on quality control of quantitative measurements of renal function obtained from the renogram: International Consensus Committee From the Scientific Committee of Radionuclides in Nephrourology. Semin Nucl Med 1999; 29: 146-159.
20. Rutland MD. A comprehensive analysis of renal DTPA studies. I. Theory and normal values. Nucl Med Commun 1985; 6: 11-20.
21. 131I-hippuran renograms. Br J Radiol 1979; 52: 134-137.
22. 99mTc-MAG3 in hypertensive patients using an uptake technique. Nucl Med Commun 1999; 20: 823-828.
23. Savitzky A, Golay MJE. Smoothing and differentiation of data by simplified least squares procedures. Anal Chem 1964; 36: 1627-1639.
24. Schlesselman JJ. Case-Control Studies. New York: Oxford University Press 1982.
25. PAH in healthy donors before and after nephrectomy. Mayo Clin Proc 1976; 51: 296-300.
26. Stabin M, Taylor A Jr., Eshima D et al. Radiation dosimetry for technetium-99m-MAG3, technetium-99m-DTPA, and iodine-131-IOH based on human biodistribution studies. J Nucl Med. 1992; 33: 33-40.
27. Sutton DG, Kempi V. Constrained least-squares restoration and renogram deconvolution: a comparison with other techniques. Phys Med Biol 1993; 38: 1043-1050.
28. Taplin GV, Meredith Jr OM, Kade H et al. The radioisotope renogram. External test for individual kidney function and upper urinary tract patency. J Lab Clin Med 1956; 48: 886-901.
29. Taylor A. Radionuclide renography: A personal approach. Semin Nucl Med 1999; 29: 102-127.
30. Taylor A, Lewis C, Giacometti A et al. Improved formulas for the estimation of renal depth in adults. J Nucl Med 1993; 34: 1766-1769.
31. Taylor A Jr, Thakore K, Folks R et al. Background subtraction in technetium-99m-MAG3 renography. J Nucl Med 1997; 38: 74-79.